(Q53120645)

11 May 2018

title

Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease. (English)

1 reference

11 May 2018

0 references

0 references

Suhail Aamar

1

1 reference

11 May 2018

Hagit Peleg

2

1 reference

11 May 2018

David Leibowitz

3

1 reference

11 May 2018

Tova Chajek-Shaul

4

1 reference

11 May 2018

Nurith Hiller

5

1 reference

11 May 2018

Samuel N Heyman

6

1 reference

11 May 2018

publication date

15 February 2013

1 reference

11 May 2018

Rheumatology International

published in

1 reference

11 May 2018

volume

34

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

857-860

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00296-013-2693-4

exact match

0 references

cites work

Chronicle of a death foretold: a case of catastrophic vascular Behcet's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Behçet's disease: a new target for anti-tumour necrosis factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Echocardiographic manifestations of Adamantiades-Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Behcet's disease with life-threatening haemoptoe and pulmonary aneurysms: complete remission after infliximab treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Cardiac Behçet disease presenting as aortic valvulitis/aortitis or right heart inflammatory mass: a clinicopathologic study of 12 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Adalimumab (Humira™): a promising monoclonal anti-tumor necrosis factor alpha in ophthalmology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Mapping the HLA association in Behçet's disease: A role for tumor necrosis factor polymorphisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2693-4

Cytokine production profile in patients with Behcet's disease treated with infliximab

21 January 2018

1 reference

12 December 2020

Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab

1 reference

12 December 2020

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab

1 reference

12 December 2020

Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab

1 reference

12 December 2020

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab

1 reference

12 December 2020

Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis

1 reference

12 December 2020

Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept

1 reference

12 December 2020

Infliximab for life-threatening pulmonary artery aneurysms in Behçet's disease. A case report

1 reference

12 December 2020

Induction of regulatory T cells by infliximab in Behcet's disease

1 reference

12 December 2020

10.1007/S00296-013-2693-4

Identifiers

DOI

1 reference

11 May 2018

PubMed ID

23412691

1 reference

11 May 2018